Prot# A6181034: A Phase 3, Randomized Study of SU011248 versus Interferon-alfa as First Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/18/044/1/12

Funding

  • PRA Health Sciences (A6181034 // A6181034)
  • Pfizer Inc. (A6181034 // A6181034)